Filter
212
Text search:
pipeline
Featured
Recommendations
25
New Publications
48
Language
Document type
No document type
88
Studies & Reports
56
Guidelines
26
Strategic & Response Plan
15
Manuals
12
Fact sheets
6
Situation Updates
5
Videos
2
Resource Platforms
1
Infographics
1
Countries / Regions
South Sudan
10
Global
8
Ethiopia
7
Kenya
6
Rwanda
6
Syria
5
Ukraine
5
India
4
Nepal
4
South Africa
4
Myanmar / Burma
4
Zambia
3
Yemen
3
East and Southern Africa
3
West and Central Africa
3
Africa
3
Liberia
2
Nigeria
2
Haiti
2
Philippines
2
Tanzania
2
China
2
Bangladesh
2
Malawi
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Uganda
1
Pakistan
1
Jordan
1
Turkey
1
Singapore
1
Sudan
1
Central African Republic
1
Hungary
1
Burundi
1
Botswana
1
Middle East and North Africa
1
Asia
1
Bhutan
1
Poland
1
Eastern Europe
1
Russia
1
Romania
1
Moldova
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
65
Key Resources
18
Clinical Guidelines
12
Pharmacy & Technologies
8
Public Health
7
Women & Child Health
7
Capacity Building
2
Toolboxes
COVID-19
34
AMR
25
Conflict
21
HIV
15
TB
15
Natural Hazards
7
NTDs
7
Planetary Health
6
Health Financing Toolbox
6
Pharmacy
3
Typhoon
2
Rapid Response
2
Mental Health
2
Global Health Education
2
Caregiver
2
Malaria
2
Ebola & Marburg
1
Polio
1
Refugee
1
Zika
1
Social Ethics
1
2.0 Rapid Response
1
29 April 2022
What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5.
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of CO
...
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitroheterocyclic drugs, benznidazole and nifurtimox, are cu
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was
...
In 2021 ACT-Accelerator will intensify its drive for equity and scale in the delivery of essential COVID-19 tools, while managing emerging viral risks. To address these major shifts and maintain momentum, ACT-Accelerator has defined four strategic priorities for 2021: Rapidly scale up the delivery o
...
Lancet Glob Health 2021 Published Online December 13, 2021 https://doi.org/10.1016/S2214-109X(21)00463-
This report brings attention to achieving gender equality in the context of women, girls, and the HIV response. This six-month consultation in 2016 with adolescent women and young girls found that #WhatWomenWant is: collaboration and joint action by all to invest in women's HIV and Sexual and Reprod
...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which
...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which
...
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
Cureus 16(2): e53933. DOI 10.7759/cureus.53933
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly
...
